DE60134816D1 - Extrakte, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre Verwendung - Google Patents

Extrakte, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre Verwendung

Info

Publication number
DE60134816D1
DE60134816D1 DE60134816T DE60134816T DE60134816D1 DE 60134816 D1 DE60134816 D1 DE 60134816D1 DE 60134816 T DE60134816 T DE 60134816T DE 60134816 T DE60134816 T DE 60134816T DE 60134816 D1 DE60134816 D1 DE 60134816D1
Authority
DE
Germany
Prior art keywords
extracts
active ingredients
pharmaceutical preparations
diabetic properties
diabetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60134816T
Other languages
English (en)
Inventor
Ian Duncan Rubin
Michael Anthony Cawthorne
Jasjit Singh Bindra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phytopharm Ltd
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9894853&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60134816(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of DE60134816D1 publication Critical patent/DE60134816D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60134816T 2000-06-30 2001-06-14 Extrakte, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre Verwendung Expired - Lifetime DE60134816D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0016213A GB2363985B (en) 2000-06-30 2000-06-30 Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use

Publications (1)

Publication Number Publication Date
DE60134816D1 true DE60134816D1 (de) 2008-08-28

Family

ID=9894853

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134816T Expired - Lifetime DE60134816D1 (de) 2000-06-30 2001-06-14 Extrakte, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre Verwendung

Country Status (12)

Country Link
US (2) US7033616B2 (de)
EP (1) EP1166792B1 (de)
JP (1) JP2002068994A (de)
AT (1) ATE401093T1 (de)
AU (1) AU784687B2 (de)
CA (1) CA2352005C (de)
DE (1) DE60134816D1 (de)
GB (1) GB2363985B (de)
HK (1) HK1043538A1 (de)
MX (1) MXPA01006802A (de)
NZ (2) NZ512505A (de)
ZA (1) ZA200105278B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046243A2 (en) * 1997-04-15 1998-10-22 Csir Pharmaceutical compositions having appetite suppressant activity
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
US20040265398A1 (en) * 2002-04-25 2004-12-30 Fleischner Albert M. Herbal composition for weight control
WO2004067009A1 (en) * 2003-01-29 2004-08-12 Dal-Hoon Son Pharmaceutical composition comprising an extract or compounds isolated from elfvingia applanata for the prevention and the treatment of diabetes and diabetic complications
TW200505461A (en) * 2003-02-14 2005-02-16 Phytopharm Plc Moldulation of ATP production or content in the hypothalamus
US7521473B2 (en) 2004-02-25 2009-04-21 Wyeth Inhibitors of protein tyrosine phosphatase 1B
RU2275930C2 (ru) * 2004-04-26 2006-05-10 ООО "РусГен" Композиция для коррекции возрастных изменений эндокринной системы человека (варианты) и способ получения фармацевтической формы на основе такой композиции
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
US20060083795A1 (en) * 2004-10-19 2006-04-20 Lima Shatkina Meal replacement products having appetite suppressing qualities
GB0425172D0 (en) * 2004-11-15 2004-12-15 Phyto Res Ltd Plant cells and uses thereof
GB0428515D0 (en) * 2004-12-30 2005-02-09 Unilever Plc Edible compositions and their preparation
CA2640335A1 (en) * 2005-06-10 2006-12-21 Mannatech, Inc. Rapid saccharide biomarker assay
US8945652B2 (en) * 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
WO2007094497A1 (ja) * 2006-02-17 2007-08-23 Use-Techno Corporation メタボリックシンドローム改善剤
US20070207227A1 (en) * 2006-02-23 2007-09-06 Conopco, Inc., D/B/A Unilever, A Corporation Of New York Appetite suppressant compositions
RU2009100892A (ru) * 2006-06-13 2010-07-20 Юнилевер Н.В. (Nl) Порционные композиции для подавления аппетита со стероидными гликозидами
JP5281234B2 (ja) * 2006-06-27 2013-09-04 ポーラ化成工業株式会社 毛様体過緊張による疲れ目の改善・予防のための経口投与組成物
MX2009001571A (es) * 2006-08-17 2009-02-19 Unilever Nv Proceso para la produccion de la planta de hoodia que contiene glucosidos esteroides.
US20080138447A1 (en) * 2006-12-06 2008-06-12 Erin John Riggins Method for administering appetite suppressant and composition thereof
WO2008074656A1 (en) * 2006-12-21 2008-06-26 Unilever N.V. Process for harvesting plants of the apocynaceae family
EP2080517A1 (de) * 2008-01-18 2009-07-22 Unilever N.V. Verfahren zur Gewinnung trockenen Pflanzenmaterials
US7923435B2 (en) 2008-04-21 2011-04-12 Phytopharm Plc Hoodia plant extract with improved flavor
US20090263510A1 (en) 2008-04-21 2009-10-22 Conopco, Inc., D/B/A Unilever Process of making Hoodia plant extract with improved flavor
AU2009325842A1 (en) * 2008-12-08 2011-07-14 Bio-Mass Ltd. Method of treatment of diseases using Hoodia extracts
EP2329836A1 (de) 2009-12-03 2011-06-08 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extrakte aus Hoodia gordonii-Zelllinien, deren Herstellung und Verwendung
WO2012022880A2 (fr) 2010-07-29 2012-02-23 Universite De Strasbourg Procede de synthese de steroïdes

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199A (en) 1845-09-19 sickels
US648967A (en) * 1899-07-15 1900-05-08 Landon M Littlefield Corn and pea planter.
US4062950A (en) 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
FR2348655A1 (fr) * 1976-04-20 1977-11-18 Sopharga Lab Nouvelle substance alimentaire ou dietetique ayant une structure alveolaire et son procede de preparation
US4185116A (en) * 1976-09-28 1980-01-22 Pfizer Inc. L- and DL- Phenylglycines to treat diseases or conditions attributable to reduced carbohydrate metabolism
DE2719912C3 (de) 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
US4130714A (en) 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
NO154918C (no) 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS5953920B2 (ja) 1977-12-28 1984-12-27 東洋醸造株式会社 新規なアミノ糖化合物およびその製法
IE47592B1 (en) 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4273763A (en) * 1978-01-23 1981-06-16 Efamol Limited Pharmaceutical and dietary compositions
JPS5745185A (en) 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
JPS5740478A (en) 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
US4791126A (en) 1980-08-22 1988-12-13 Ono Pharmaceutical Co., Ltd. Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredients
EP0056194B1 (de) 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. N-substituierte Pseudo-Aminozucker, ihre Herstellung und Verwendung
CA1176269A (en) 1981-03-02 1984-10-16 Kazimir Sestanj N-naphthoylglycine derivatives
US4377500A (en) 1981-07-08 1983-03-22 The Standard Oil Co. Catalysts
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4883880A (en) * 1982-05-03 1989-11-28 Agfa-Gevaert Aktiengessellschaft Process for the preparation of sulfoalkyl quaternary salts and for the production of alkane sultones
JPS58194818A (ja) 1982-05-10 1983-11-12 Iwasaki Shuzo サボテン中の水溶性多糖及び繊維の取得方法
ES524614A0 (es) * 1982-08-12 1984-05-01 Nativelle Sa Ets Procedimiento de preparacion de nuevos amino-14 esteroides.
AU570439B2 (en) 1983-03-28 1988-03-17 Compression Labs, Inc. A combined intraframe and interframe transform coding system
HU201675B (en) 1983-08-26 1990-12-28 Ivan Balkanyi Process for producing oral pharmaceutical compositions with unappetizing effect
US5066659A (en) 1984-10-30 1991-11-19 Pfizer Inc. Spiro-heteroazalones for treatment of diabetic complications
US4634765A (en) 1984-12-18 1987-01-06 Merrell Dow Pharmaceuticals Inc. Homodisaccharide hypoglycemic agents
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
US5246960A (en) * 1984-12-21 1993-09-21 Hoffmann-La Roche Inc. Oxetanones
IT1207504B (it) 1985-09-26 1989-05-25 Crinos Industria Farmaco Composizione moderatrice dell'appetito ed antigastrica.
IT1190400B (it) 1985-10-04 1988-02-16 Istituto Biochimico Italiano Derivati dell'acido 19,20-bis,nor-prostanoico ad attivita' antiulcera e anoressivca,procedimento per la loro preparazione e composizioni farmaceutiche
GB8524663D0 (en) 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives
US4939140A (en) 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
US4757151A (en) 1985-11-14 1988-07-12 Warner-Lambert Company 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]
US4652553A (en) * 1985-11-25 1987-03-24 Merck & Co., Inc. Steroidal glycolipids as host resistance stimulators
GB8600489D0 (en) * 1986-01-09 1986-02-12 Erba Farmitalia Aminoglycoside steroids
AU602641B2 (en) 1986-04-17 1990-10-18 Senju Pharmaceutical Co., Ltd. Thiolactam-N-acetic acid derivatives, their production and use
EP0264586B1 (de) 1986-08-28 1991-04-03 Sanwa Kagaku Kenkyusho Co., Ltd. Hydantoin-Derivate zur Behandlung von Komplikationen bei Diabetes
ZA883929B (en) 1987-06-22 1990-02-28 Hoffmann La Roche Cholecystokinin analogs for controlling appetite
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
US5192772A (en) 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
GB8801037D0 (en) * 1988-01-18 1988-02-17 Plessey Co Ltd Improvements relating to fuel supply systems
US5252572A (en) 1988-02-03 1993-10-12 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. Pyridopyrimidine derivatives, pharmaceutical compositions containing them and process for preparing same
EP0344383A1 (de) 1988-06-02 1989-12-06 Merrell Dow Pharmaceuticals Inc. Alpha-Glucosidase-Inhibitoren
DE3836675A1 (de) 1988-10-28 1990-05-03 Hoechst Ag Glykosidase-inhibitor salbostatin, verfahren zu seiner herstellung und seine verwendung
US4978669A (en) 1989-06-08 1990-12-18 Neurex Corporation Method of suppressing appetite by administration of tetrahydro-beta-carboline derivatives
JPH03120227A (ja) * 1989-10-02 1991-05-22 Shigeo Ochi 飲食物消化分解産物吸収抑制剤
US4980357A (en) 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives
US5037831A (en) 1990-05-21 1991-08-06 American Home Products Corporation Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
US5504078A (en) 1990-06-08 1996-04-02 Merrell Dow Pharmaceuticals Inc. α-glucosidase inhibitors
GB9016978D0 (en) 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
US5091418A (en) 1990-09-28 1992-02-25 Bristol-Myers Squibb Company Novel alpha-glucosidase inhibitor, pradimicin Q
US5217877A (en) 1990-09-28 1993-06-08 Bristol-Myers Squibb Company Process for the preparation of α-glucosidase inhibitor, pradimicin Q
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
AU683620B2 (en) 1992-09-28 1997-11-20 Pfizer Inc. Substituted pyrimidines for control of diabetic complications
RU2115255C1 (ru) 1992-09-30 1998-07-10 Моторола, Инк. Способ доставки сообщений, система связи и портативный приемник селективного вызова для осуществления способа
GB9307833D0 (en) 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin
FR2706255B1 (fr) 1993-06-17 1995-10-27 Univ Rennes Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques.
CA2165200A1 (en) 1993-06-18 1995-01-05 Ambikaipakan Balasubramaniam Neuropeptide y antagonists and agonists
US5516516A (en) * 1993-10-19 1996-05-14 Cherksey; Bruce D. Method of preparing muira puama extract and its use for decreasing body fat percentage and increasing lean muscle mass
JPH07184548A (ja) * 1993-12-28 1995-07-25 Meiji Seito Kk 口腔用組成物
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
ZA96626B (en) 1995-02-09 1996-08-15 Sastech Pty Ltd Copolymerization
US5698199A (en) * 1995-03-10 1997-12-16 Kao Corporation Lipolysis acceleration method
ATE205477T1 (de) 1995-06-06 2001-09-15 Pfizer Substituierte n-(indol-2-carbonyl)-amide und derivate als glycogen phosphorylase inhibitoren
MX9709875A (es) 1995-06-06 1998-03-31 Pfizer N-(indol-2-carbonil)-glicinamidas substituidas y derivados como inhibidores de glicogeno fosforilasa, composiciones que las contienen y uso de las mismas.
US5693327A (en) * 1995-07-12 1997-12-02 Shah; Eladevi Herbal compositions
EP0862631A1 (de) 1995-10-26 1998-09-09 The Board Of Regents, The University Of Texas System Luminaler, cholecystokinin-freisetzender faktor
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
DE69738695D1 (de) 1996-03-01 2008-06-26 Novo Nordisk As Peptid zur Appetitzügelung, dessen Zusammensetzungen und Verwendung
US5908609A (en) * 1996-06-10 1999-06-01 Millennium Pharmaceuticals, Inc. Screening methods for compounds useful in the regulation of body weight
US5932779A (en) 1996-06-10 1999-08-03 Millennium Pharmaceuticals, Inc. Screening methods for compounds useful in the regulation of body weight
AU5243798A (en) 1996-11-06 1998-05-29 Children's Medical Center Corporation Transgenic animal expressing a syndecan in the regions of hypothalamus
WO1998027113A2 (en) 1996-12-17 1998-06-25 Quadrant Holdings Cambridge Limited Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
CA2217698A1 (en) 1996-12-20 1998-06-20 Eli Lilly And Company Anti-obesity proteins
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
EP0971957A1 (de) 1997-03-26 2000-01-19 Novo Nordisk A/S Polypeptid mit appetit regulierender aktivität
WO1998046243A2 (en) * 1997-04-15 1998-10-22 Csir Pharmaceutical compositions having appetite suppressant activity
FR2771105A1 (fr) * 1997-11-20 1999-05-21 Vitasterol Utilisation du fusarium monoliforme pour la preparation des derives 7alpha-hydroxyles de la dehydroepiandrosterone et de la pregnenolone
HUP9803039A2 (hu) 1998-12-30 2000-09-28 István Lelkes Az elhízás kezelésére, megelőzésére, szövődményei kialakulásának kivédésére, a kialakult szövődmények kezelésére szolgáló gyógyászati kompozíció
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use

Also Published As

Publication number Publication date
JP2002068994A (ja) 2002-03-08
CA2352005A1 (en) 2001-12-30
ZA200105278B (en) 2002-01-07
MXPA01006802A (es) 2003-08-20
GB2363985B (en) 2004-09-29
US20060159779A1 (en) 2006-07-20
EP1166792A2 (de) 2002-01-02
AU5407801A (en) 2002-01-03
GB2363985A (en) 2002-01-16
US20020146468A1 (en) 2002-10-10
NZ523175A (en) 2005-04-29
US7033616B2 (en) 2006-04-25
HK1043538A1 (zh) 2002-09-20
EP1166792A3 (de) 2003-03-05
US7416744B2 (en) 2008-08-26
EP1166792B1 (de) 2008-07-16
AU784687B2 (en) 2006-06-01
CA2352005C (en) 2011-01-04
NZ512505A (en) 2003-05-30
GB0016213D0 (en) 2000-08-23
ATE401093T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
DE60134816D1 (de) Extrakte, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre Verwendung
HUP0000838A2 (hu) Szteroid-glikozidot tartalmazó extraktum, eljárás izolálására és szintetikus előállítására, valamint ezt tartalmazó étvágycsökkentő gyógyszerkészítmények
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
MY115339A (en) Compositions containing micronized nebivolol
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
CA2295035A1 (en) Pharmaceutical formulations containing voriconazole
ATE329608T1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
ATE246497T1 (de) Fluorchlorkohlenwasserstoffreie aerosolformulierungen
EA200400730A1 (ru) Ингалятор контролируемой дозы
DE60228761D1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
ATE146360T1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
BR9810495A (pt) Composição farmacêutica
ATE137958T1 (de) Pharmazeutische aerosolzubereitung sowie deren verwendung zur behandlung und prophylaxe viraler erkrankungen
WO2005065639A3 (en) Novel pharmaceutical compositions
DE59401618D1 (de) Präparate aus crataegus-arten, arzneimittel und ihre verwendung zur verhinderung des plötzlichen herztodes sowie von reperfusions-bedingten cardiovaskulären schädigungen
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
WO2002062952A3 (en) Non-cytotoxic pap mutants
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
WO2003018535A3 (en) Novel aminobenzoephenones
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
TR199900523T2 (xx) Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler.
IT1306147B1 (it) Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
JP2002020308A5 (de)
EP0820771A3 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: MEISSNER, BOLTE & PARTNER GBR, 80538 MUENCHEN

8327 Change in the person/name/address of the patent owner

Owner name: PHYTOPHARM PLC, GODMANCHESTER, CAMBRIDGESHIRE, GB

8363 Opposition against the patent